Heat shock protein 27 in chronic allograft nephropathy: A local stress response

Transplantation

Volumn 79, Issue 12, 2005, Pages 1645-1657

  Djamali, Arjang ^a,c   Reese, Shannon ^a   Oberley, Terry ^b   Hullett, Debra ^a   Becker, Bryan ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NONE   (United States)

Author keywords

Bax p38 MAPK; Chronic allograft nephropathy; FasL; HSP27; Hypoxia; Oxidative stress

Indexed keywords

CD3 ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE; FAS LIGAND; HEAT SHOCK PROTEIN 27; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA MICROARRAY; FIBROSING ALVEOLITIS; GENE SEQUENCE; GLOMERULOSCLEROSIS; GRAFT REJECTION; HYPOXIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY ALLOGRAFT; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; STRESS;

ANIMALS; BASE SEQUENCE; CHRONIC DISEASE; HEAT-SHOCK PROTEINS; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY TRANSPLANTATION; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 21244487076     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000164319.83159.A7     Document Type: Article

References (69)

1. Gottmann U, Oltersdorf J, Schaub M, et al. Oxidative stress in chronic renal allograft nephropathy in rats: Effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol. J Cardiovasc Pharmacol 2003; 42: 442-450.
2. Cristol JP, Vela C, Maggi MF, et al. Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation 1998; 65: 1322-1328.
3. Simic-Ogrizovic S, Simic T, Reljic Z, et al. Markers of oxidative stress after renal transplantation. Transpl Int 1998; 11(suppl 1): S125-S129.
4. Albrecht EW, Stegeman CA, Tiebosch AT, et al. Expression of inducible and endothelial nitric oxide synthases, formation of peroxynitrite and reactive oxygen species in human chronic renal transplant failure. Am J Transplant 2002; 2: 448-453.
5. MacMillan-Crow LA, Crow JP, Kerby JD, et al. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 1996; 93: 11853-11858.
6. Raj DS, Lim G, Levi M, et al. Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy. Am J Kidney Dis 2004; 43: 154-160.
7. Djamali A, Reese S, Yracheta J, et al. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant. 2005; 5(3): 500-509.
8. Zou AP, Cowley AW Jr. Reactive oxygen species and molecular regulation of renal oxygenation. Acta Physiol Scand 2003; 179: 233-241.
9. Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2002; 13: 1338-1349.
10. Manotham K, Tanaka T, Matsumoto M, et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004; 15: 1277-1288.
11. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med 2004; 43: 9-17.
12. Manotham K, Tanaka T, Matsumoto M, et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 2004; 65: 871-880.
13. Eckardt KU, Rosenberger C, Jurgensen JS, et al. Role of hypoxia in the pathogenesis of renal disease. Blood Purif 2003; 21: 253-257.
14. Kabakov AE, Budagova KR, Bryantsev AL, et al. Heat shock protein 70 or heat shock protein 27 overexpressed in human endothelial cells during posthypoxic reoxygenation can protect from delayed apoptosis. Cell Stress Chaperones 2003; 8: 335-347.
15. Creagh EM, Sheehan D, Cotter TG. Heat shock proteins: Modulators of apoptosis in tumour cells. Leukemia 2000; 14: 1161-1173.
16. Mounier N, Arrigo AP. Actin cytoskeleton and small heat shock proteins: How do they interact? Cell Stress Chaperones 2002; 7: 167-176.
17. Guay J, Lambert H, Gingras-Breton G, et al. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 1997; 110: 357-368.
18. Lavoie JN, Lambert H, Hickey E, et al. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation- induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 1995; 15: 505-516.
19. Lavoie JN, Hickey E, Weber LA, et al. Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem 1993; 268: 24210-24214.
20. Bruey JM, Ducasse C, Bonniaud P, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000; 2: 645-652.
21. Charette SJ, Lavoie JN, Lambert H, et al. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol 2000; 20: 7602-7612.
22. Arrigo AP. Small stress proteins: Chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem 1998; 379: 19-26.
23. Mehlen P, Hickey E, Weber LA, et al. Large unphosphorylated aggregates as the active form of hsp27 which controls intracellular reactive oxygen species and glutathione levels and generates a protection against TNFalpha in NIH-3T3-ras cells. Biochem Biophys Res Commun 1997; 241: 187-192.
24. Khan W, McGuirt JP, Sens MA, et al. Expression of heat shock protein 27 in developing and adult human kidney. Toxicol Lett 1996; 84: 69-79.
25. Brezis M, Rosen S. Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 1995; 332: 647-655.
26. Muller E, Neuhofer W, Ohno A, et al. Heat shock proteins HSP25, HSP60, HSP72, HSP73 in isoosmotic cortex and hyperosmotic medulla of rat kidney. Pflugers Arch 1996; 431: 608-617.
27. Beck FX, Burger-Kentischer A, Muller E. Cellular response to osmotic stress in the renal medulla. Pflugers Arch 1998; 436: 814-827.
28. Neuhofer W, Muller E, Burger-Kentischer A, et al. Hypertonicity affects heat shock protein 27 and F-actin localization in Madin-Darby canine kidney cells. Kidney Int Suppl 1998; 67: S165-S167.
29. Smoyer WE, Ransom R, Harris RC, et al. Ischemic acute renal failure induces differential expression of small heat shock proteins. J Am Soc Nephrol 2000; 11: 211-221.
30. Schober A, Muller E, Thurau K, et al. The response of heat shock proteins 25 and 72 to ischaemia in different kidney zones. Pflugers Arch 1997; 434: 292-299.
31. Schober A, Burger-Kentischer A, Muller E, et al. Effect of ischemia on localization of heat shock protein 25 in kidney. Kidney Int Suppl 1998; 67: S174-S176.
32. Aufricht C, Ardito T, Thulin G, et al. Heat-shock protein 25 induction and redistribution during actin reorganization after renal ischemia. Am J Physiol 1998; 274: F215-F222.
33. Bitar KN, Kaminski MS, Hailat N, et al. Hsp27 is a mediator of sustained smooth muscle contraction in response to bombesin. Biochem Biophys Res Commun 1991; 181: 1192-1200.
34. Muller E, Burger-Kentischer A, Neuhofer W, et al. Possible involvement of heat shock protein 25 in the angiotensin II-induced glomerular mesangial cell contraction via p38 MAP kinase. J Cell Physiol 1999; 181: 462-469.
35. Park KM, Kramers C, Vayssier-Taussat M, et al. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 2002; 277: 2040-2049.
36. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001; 276: 11870-11876.
37. Basile DP, Donohoe D, Cao X, et al. Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection. Kidney Int 2004; 65: 2201-2211.
38. Valles P, Jorro F, Carrizo L, et al. Heat shock proteins HSP27 and HSP70 in unilateral obstructed kidneys. Pediatr Nephrol 2003; 18: 527-535.
39. Jolicoeur EM, Qi S, Xu D, et al. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat. Transplantation 2003; 75: 54-59.
40. Becker BN, Jacobson LM, Hullett DA, et al. Type 2 angiotensin II receptor expression in human renal allografts: An association with chronic allograft nephropathy. Clin Nephrol 2002; 57: 19-26.
41. Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis: Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 1996; 271: 16510-16514.
42. Charette SJ, Landry J. The interaction of HSP27 with Daxx identifies a potential regulatory role of HSP27 in Fas-induced apoptosis. Ann N Y Acad Sci 2000; 926: 126-131.
43. Gerner C, Frohwein U, Gotzmann J, et al. The Fas-induced apoptosis analyzed by high throughput proteome analysis. J Biol Chem 2000; 275: 39018-39026.
44. Preville X, Schultz H, Knauf U, et al. Analysis of the role of Hsp25 phosphorylation reveals the importance of the oligomerization state of this small heat shock protein in its protective function against TNFalpha- and hydrogen peroxide-induced cell death. J Cell Biochem 1998; 69: 436-452.
45. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
46. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52: 11-34.
47. Yoshizumi M, Tsuchiya K, Tamaki T. Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease. J Med Invest 2001; 48: 11-24.
48. Dalle-Donne I, Rossi R, Milzani A, et al. The actin cytoskeleton response to oxidants: From small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic Biol Med 2001; 31: 1624-1632.
49. Dorion S, Landry J. Activation of the mitogen-activated protein kinase pathways by heat shock. Cell Stress Chaperones 2002; 7: 200-206.
50. Huot J, Houle F, Rousseau S, et al. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol 1998; 143: 1361-1373.
51. Pichon S, Bryckaert M, Berrou E. Control of actin dynamics by p38 MAP kinase-Hsp27 distribution in the lamellipodium of smooth muscle cells. J Cell Sci 2004; 117: 2569-2577.
52. Alevy YG, Brennan D, Durriya S, et al. Increased expression of the HDJ-2 heat shock protein in biopsies of human rejected kidney. Transplantation 1996; 61: 963-967.
53. Yan LJ, Christians ES, Liu L, et al. Mouse heat shock transcription factor 1 deficiency alters cardiac redox homeostasis and increases mitochondrial oxidative damage. EMBO J 2002; 21: 5164-5172.
54. Brune B, Zhou J, von Knethen A. Nitric oxide, oxidative stress, and apoptosis. Kidney Int Suppl 2003; 84: S22-S24.
55. Kietzmann T, Jungermann K, Gorlach A. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thromb Haemost 2003; 89: 666-673.
56. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12.
57. Epstein FH, Agmon Y, Brezis M. Physiology of renal hypoxia. Ann N Y Acad Sci 1994; 718: 72-81.
58. Hildeman DA, Mitchell T, Kappler J, et al. T cell apoptosis and reactive oxygen species. J Clin Invest 2003; 111: 575-581.
59. Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 2004; 13: 93-99.
60. Ueda S, Masutani H, Nakamura H, et al. Redox control of cell death. Antioxid Redox Signal 2002; 4: 405-414.
61. Maxwell P. HIF-1: An oxygen response system with special relevance to the kidney. J Am Soc Nephrol 2003; 14: 2712-2722.
62. Rosenberger C, Mandriota S, Jurgensen JS, et al. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002; 13: 1721-1732.
63. Djamali A, Sadowski E, Hofmann RM, et al. Acute graft rejection assessed by blood oxygenation level-dependent (BOLD) MRI. Am J Transplant 2004; 4: 164.
64. Djamali A, Sadowski E, Muehrer R, et al. Losartan improves renal medullary oxygenation and oxidative stress in patients with chronic allograft nephropathy. J Am Soc Nephrol 2004; 15: SA-PO1026.
65. Prasad PV, Priatna A, Spokes K, et al. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging 2001; 13: 744-747.
66. Epstein FH, Prasad P. Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int 2000; 57: 2080-2083.
67. Prasad PV, Epstein FH. Changes in renal medullary pO2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: Effects of aging and cyclooxygenase inhibition. Kidney Int 1999; 55: 294-298.
68. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996; 94: 3271-3275.
69. Prasad PV, Chen Q, Goldfarb JW, et al. Breath-hold R2* mapping with a multiple gradient-recalled echo sequence: Application to the evaluation of intrarenal oxygenation. J Magn Reson Imaging 1997; 7: 1163-1165.